aTyr Pharma to Host Conference Call and Webcast of Third Quarter 2018 Financial Results on November 13, 2018
November 08 2018 - 8:00AM
aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged
in the discovery and development of innovative medicines based on
novel immunological pathways, today announced that it will report
its third quarter financial results on Tuesday, November 13, 2018
after the close of the U.S. financial markets. Company management
will host a conference call and audio webcast on Tuesday, November
13, 2018 at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time to
discuss the results and provide a corporate update.
Interested parties may access the call by
dialing toll-free (844) 358-9116 from the U.S. or (209) 905-5951
internationally and using conference ID 4389274.
The press release and links to a live audio
webcast and replay may be accessed on the aTyr website events page
at: http://investors.atyrpharma.com/events-and-webcasts. An audio
replay will be available for at least 90 days following the
event.
About aTyr
aTyr is a biotherapeutics company engaged in the
discovery and development of innovative medicines based on novel
immunological pathways. aTyr’s research and development
efforts are concentrated on a newly discovered area of biology, the
extracellular functionality of tRNA synthetases. aTyr has built a
global intellectual property estate directed to a potential
pipeline of protein compositions derived from 20 tRNA synthetase
genes. aTyr is focused on the therapeutic translation of the
Resokine pathway, comprised of extracellular proteins derived from
the histidyl tRNA synthetase gene family. ATYR1923 is a
clinical-stage product candidate which binds to the neuropilin-2
receptor and is designed to down-regulate immune engagement in
interstitial lung diseases and other immune-mediated
diseases. For more information, please visit
http://www.atyrpharma.com.
Contact: |
|
Jason Spark |
|
Managing Director, Canale Communications Inc |
|
jason@canalecomm.com |
|
619-849-6005 |
|
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Apr 2023 to Apr 2024